{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifwwlawobqnhp2svo6y7kwizhtfnxnogxf76kyhy6rk7focire3iu",
    "uri": "at://did:plc:n4cc2hzkznfsuygxedzu744k/app.bsky.feed.post/3mo2etcamu362"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreib3kigthwbtxalr2shsqs5im6pvvei363dc4yginqbrlkpka5uaxi"
    },
    "mimeType": "image/png",
    "size": 524971
  },
  "path": "/patients-over-patents-the-left-alternative-for-a-public-eu-pharma-industry/",
  "publishedAt": "2026-06-11T08:19:21.000Z",
  "site": "https://left.eu",
  "tags": [
    "News"
  ],
  "textContent": "Medicine shortages and rising prices are increasingly undermining patients’ access to essential treatments across Europe. At The Left event bringing together elected representatives, trade unionists, health advocates and healthcare workers, one message was clear: medicines must be treated as a public good, not a source of private profit. Participants highlighted how decades of outsourcing, market […]",
  "title": "Patients over Patents: The Left alternative for a Public EU Pharma Industry"
}